KYMR Kymera Therapeutics Forecast, Technical & Fundamental Analysis
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives... Show more
KYMR is expected to report earnings to rise 3.13% to -73 cents per share on July 31
Q2'26
Est.
$-0.73
Q1'26
Beat
by $0.17
Q4'25
Missed
by $0.18
Q3'25
Missed
by $0.18
Q2'25
Missed
by $0.12
The last earnings report on April 30 showed earnings per share of -70 cents, beating the estimate of -87 cents. With 39.64K shares outstanding, the current market capitalization sits at 6.10B.
A.I. Advisor
published General Information
General Information
a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics
A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with GPCR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then GPCR could also see price increases.
KYMR in upward trend: price may jump up because it broke its lower Bollinger Band on June 02, 2026
KYMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 46 cases where KYMR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where KYMR's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where KYMR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KYMR advanced for three days, in of 297 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on May 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KYMR as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
KYMR moved below its 50-day moving average on May 15, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for KYMR crossed bearishly below the 50-day moving average on May 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KYMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for KYMR entered a downward trend on May 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KYMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.960) is normal, around the industry mean (19.817). P/E Ratio (0.000) is within average values for comparable stocks, (36.300). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.691). KYMR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.039). P/S Ratio (128.205) is also within normal values, averaging (355.038).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
